−£1.80m
vs Nov 2024Active12293407Private limited companyLondon
EXOGENE LIMITED
D47/10001
Summary
EXOGENE LIMITED is an active private limited company (company number 12293407) incorporated on 1 November 2019, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 November 2025, showing net assets of −£1.80m and cash of £210k, with 6 employees on average. Net assets fell 10% on the prior period (−£1.63m).
Peer position · net assets
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Key dates
- Incorporated
- 1 November 20196 yrs ago
- Next accounts due
- 30 August 2027in 312 days
- Confirmation statement due
- 15 November 2026in 24 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
04
Financials
£210k
+112%vs Nov 2024Not reported
6
No changevs Nov 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | −£1.80m | £210k | £258k | — | — | — | 6 |
| 30 November 2024 | −£1.63m | £99k | £399k | — | — | — | 6 |
Cash per employee£35kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
05
Firmoscan score
47 / 100 · grade D
| 50 | Starting scoreEvery scored company starts here |
| −15 | Negative net assetsNet assets £-1,802,036 at 2025-11-30 |
| +4 | Cash reservesCash £210,230 |
| +8 | EstablishedIncorporated 2019-11-01 (7 years) |
| 47 | Score, grade D |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Dr Federico Paoletti
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Andrea Mambrini
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Next accounts duein 312 days
- Confirmation statement duein 24 days
- Accounts period endNet liabilities £1.80m · small accounts
- Accounts period endNet liabilities £1.63m · small accounts
- Incorporated
08
Similar companies in London
- TECREA ANIMAL HEALTH LIMITEDLondon · inc. Nov 2019
- BASEIMMUNE LTDLondon · inc. Oct 2019
- MEVOX LTDLondon · inc. Oct 2019
- GREY MEDICAL LTDLondon · inc. Nov 2019
- RELATION THERAPEUTICS LIMITEDLondon · inc. Nov 2019
- BIOCOMPLIANCE CONSULTANCY LTDLondon · inc. Oct 2019
All companies incorporated on 1 November 2019 · in Nov 2019.
09
Reminders for EXOGENE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.